CD4 and disease arising from reactivation of latent virus: Therefore, the proteins encoded by DosR and EHR genes have been investigated as candidate vaccine antigens, such that these proteins could be targeted by therapeutic vaccine strategies that would prevent reactivation of Mtb from latent infection.42 In fact, several of these proteins are immunogenic for CD4+ T cells in humans with LTBI (reviewed in ref. 24).